TTD Drug ID: DNC014099

Drug Information
Name	Eusynstyelamide C
Indication	Not Available			Experimental
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
InChI	1S/C32H40Br2N10O4/c33-19-5-7-21-18(16-42-24(21)13-19)15-31(47)26( 23-17-43-25-14-20(34)6-8-22(23)25)32(48,27(45)39-9-1-2-10-40-29(3 5)36)44(28(31)46)12-4-3-11-41-30(37)38/h5-8,13-14,16-17,26,42-43, 47-48H,1-4,9-12,15H2,(H,39,45)(H4,35,36,40)(H4,37,38,41)/t26-,31- ,32+/m1/s1
InChIKey	AFCHPUCHYPXZGZ-WBKIGWJKSA-N
Canonical SMILES	C1=CC2=C(C=C1Br)NC=C2CC3(C(C(N(C3=O)CCCCN=C(N)N)(C(=O)NCCCCN=C(N)N)O)C4= CNC5=C4C=CC(=C5)Br)O
Isomeric SMILES	C1=CC2=C(C=C1Br)NC=C2C[C@]3([C@H]([C@@](N(C3=O)CCCCN=C(N)N)(C(=O)NCCCCN= C(N)N)O)C4=CNC5=C4C=CC(=C5)Br)O
Target	Nitric-oxide synthase, brain			Inhibitor	[1]
Ref 1	J Nat Prod. 2009 Jun;72(6):1115-20.Eusynstyelamides A, B, and C, nNOS inhibitors, from the ascidian Eusynstyela latericius. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.